| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 332 | 10.252 | 10.751 | 3.036 | 210 | 165 | 26 | 99 |
| Total Income - EUR | - | - | 332 | 10.252 | 10.751 | 3.036 | 210 | 165 | 35 | 99 |
| Total Expenses - EUR | - | - | 315 | 247 | 162 | 126 | 96 | 98 | 36 | 0 |
| Gross Profit/Loss - EUR | - | - | 17 | 10.006 | 10.589 | 2.910 | 114 | 68 | -1 | 99 |
| Net Profit/Loss - EUR | - | - | 7 | 9.698 | 10.267 | 2.825 | 108 | 63 | -1 | 84 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cusciac Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 248 | 9.893 | 19.981 | 22.382 | 270 | 338 | 328 | 425 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 102 | 222 | 51 | 0 | 33 | 0 | 0 | 0 |
| Cash | - | - | 146 | 9.671 | 19.930 | 22.382 | 237 | 338 | 328 | 425 |
| Shareholders Funds | - | - | 51 | 9.748 | 19.826 | 22.275 | 157 | 220 | 218 | 300 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 217 | 145 | 156 | 107 | 113 | 118 | 110 | 125 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cusciac Med Srl